IMMray™ technology
Автор: immunovia
Загружено: 2018-01-31
Просмотров: 1965
IMMray™ PanCan–d is the first blood-based test for early and specific (differential) diagnosis, providing clinicians with actionable information. Immunovia has defined a clinically relevant condensed panel of serum biomarkers (a biomarker signature) associated with pancreatic adenocarcinoma. This biomarker panel can be used for differential diagnosis at an early stage of the cancer. The test is suitable for screening risk-groups as well as investigating patients with suspected symptoms.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: